Coherus BioSciences
(NASDAQ:CHRS)
$2.19
-0.22[-9.13%]
At close: Apr 12
$2.19
0[0.00%]
After Hours: 7:30PM EDT

Coherus BioSciences Stock (NASDAQ:CHRS), Guidance and Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Date Announced
ticker
Company Name
Period
Period Year
Min EPS
Max EPS
Estimate
Min Rev
Max Rev
Revenue Estimate
Get Alert
01/10/2024CHRS
Coherus BioSciences
Q42023$90.00M$95.68MGet Alert
01/10/2024CHRS
Coherus BioSciences
FY2023$260.00M$260.00M$260.53MGet Alert
11/06/2023CHRS
Coherus BioSciences
FY2023$250.00M$260.00M$288.19MGet Alert
08/02/2023CHRS
Coherus BioSciences
FY2023$275.00M$266.16MGet Alert
05/08/2023CHRS
Coherus BioSciences
FY2023$275.00M$344.75MGet Alert
04/13/2020CHRS
Coherus BioSciences
Q12020$115.00M$117.50M$118.85MGet Alert

FAQ

Q

What is the most recent guidance for Coherus BioSciences (CHRS)?

A

There have been no specific sales or earnings guidance reported for Coherus BioSciences in recent months.

Browse guidance and forecast on all stocks.

People Also Watch